Daygnosys

Dyagnosys is a B2B SaaS company revolutionizing workplace mental health through AI-powered, privacy-first wellbeing assessment technology. Our platform combines clinically-validated psychometric tools (GAD-7) with real-time biometric analysis to provide organizations with unprecedented visibility into employee wellbeing—without compromising privacy.

Our Mission: To make mental health monitoring as accessible and routine as physical health monitoring, enabling early intervention and preventing burnout before it impacts performance.

The Problem: 76% of workers report burnout symptoms, costing the global economy $1 trillion annually in lost productivity due to depression and anxiety. Current solutions fail because they store sensitive biometric data in the cloud, rely on infrequent self-reported surveys, and lack clinical validation.

Our Solution: Dyagnosys is the first wellbeing assessment platform combining clinical validation (GAD-7 anxiety screening), biometric intelligence (18 behavioral signals via camera and voice), privacy-first architecture (hybrid on-device processing), and enterprise compliance (GDPR, LGPD, HIPAA-ready). All biometric data is processed on-device using MediaPipe and WebLLM—raw data never leaves the user's device.

Traction: Product launched with full biometric capabilities, first enterprise pilot secured with Petrobras, active clinical trial through Brazil-Switzerland bilateral agreement, and partnerships with ApexBrasil, Sebrae DF, and UFMG. Headquartered in Spain with operations across EU and LATAM.

Team: Founded by experienced leaders in enterprise SaaS, AI/ML engineering, clinical psychology, and B2B sales, with an advisory board including experts from WHO, technical universities, and Fortune 500 companies.